| The economic burden of treatment-resistant depression N Olchanski, MMI Myers, M Halseth, PL Cyr, L Bockstedt, TF Goss, ... Clinical therapeutics 35 (4), 512-522, 2013 | 204 | 2013 |
| Growth and quality of the cost–utility literature, 1976–2001 PJ Neumann, D Greenberg, NV Olchanski, PW Stone, AB Rosen Value in Health 8 (1), 3-9, 2005 | 185 | 2005 |
| Cost-utility analyses in orthopaedic surgery CA Brauer, AB Rosen, NV Olchanski, PJ Neumann JBJS 87 (6), 1253-1259, 2005 | 146 | 2005 |
| Cost-utility analysis studies of depression management: a systematic review PA Pirraglia, AB Rosen, RC Hermann, NV Olchanski, P Neumann American Journal of Psychiatry 161 (12), 2155-2162, 2004 | 123 | 2004 |
| Dementia diagnosis disparities by race and ethnicity PJ Lin, AT Daly, N Olchanski, JT Cohen, PJ Neumann, JD Faul, HM Fillit, ... Medical Care 59 (8), 679-686, 2021 | 85 | 2021 |
| Palivizumab prophylaxis for respiratory syncytial virus: examining the evidence around value N Olchanski, RN Hansen, E Pope, B D’Cruz, J Fergie, M Goldstein, ... Open Forum Infectious Diseases 5 (3), ofy031, 2018 | 74 | 2018 |
| Can we better prioritize resources for cost-utility research? PJ Neumann, AB Rosen, D Greenberg, NV Olchanski, R Pande, ... Medical decision making 25 (4), 429-436, 2005 | 51 | 2005 |
| Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of acute ST-segment elevation myocardial infarction M Schwenkglenks, TJ Toward, S Plent, TD Szucs, DJ Blackman, ... Heart 98 (7), 544-551, 2012 | 42 | 2012 |
| Quality of abstracts of papers reporting original cost-effectiveness analyses AB Rosen, D Greenberg, PW Stone, NV Olchanski, PJ Neumann Medical decision making 25 (4), 424-428, 2005 | 41 | 2005 |
| Effect of serum sodium concentration and tolvaptan treatment on length of hospitalization in patients with heart failure PL Cyr, KA Slawsky, N Olchanski, HB Krasa, TF Goss, C Zimmer, ... American Journal of Health-System Pharmacy 68 (4), 328-333, 2011 | 36 | 2011 |
| Assessment of the influence of test characteristics on the clinical and cost impacts of methicillin-resistant Staphylococcus aureus screening programs in US hospitals. JW Olchanski N, Mathews C, Fusfeld L Infect Control Hosp Epidemiol. 32 (3), 250-257, 2011 | 35 | 2011 |
| Abdominal aortic aneurysm screening: how many life years lost from underuse of the medicare screening benefit? N Olchanski, A Winn, JT Cohen, PJ Neumann Journal of general internal medicine 29, 1155-1161, 2014 | 34 | 2014 |
| Racial and ethnic differences in hospice use and hospitalizations at end-of-life among Medicare beneficiaries with dementia PJ Lin, Y Zhu, N Olchanski, JT Cohen, PJ Neumann, JD Faul, HM Fillit, ... JAMA Network Open 5 (6), e2216260-e2216260, 2022 | 32 | 2022 |
| Can a novel ICU data display positively affect patient outcomes and save lives? N Olchanski, MA Dziadzko, IC Tiong, CE Daniels, SG Peters, JC O’horo, ... Journal of medical systems 41, 1-8, 2017 | 29 | 2017 |
| Delays in publication of cost utility analyses conducted alongside clinical trials: registry analysis D Greenberg, AB Rosen, NV Olchanski, PW Stone, J Nadai, PJ Neumann BMJ 328 (7455), 1536-1537, 2004 | 29 | 2004 |
| The peculiar economics of life-extending therapies: a review of costing methods in health economic evaluations in oncology N Olchanski, Y Zhong, JT Cohen, C Saret, M Bala, PJ Neumann Expert review of pharmacoeconomics & outcomes research 15 (6), 931-940, 2015 | 25 | 2015 |
| Cost comparison across heart failure patients with reduced and preserved ejection fractions: analyses of inpatient decompensated heart failure admissions N Olchanski, AR Vest, JT Cohen, PJ Neumann, D DeNofrio International Journal of Cardiology 261, 103-108, 2018 | 22 | 2018 |
| Patient variability seldom assessed in cost-effectiveness studies TA Lavelle, DM Kent, CM Lundquist, T Thorat, JT Cohen, JB Wong, ... Medical Decision Making 38 (4), 487-494, 2018 | 22 | 2018 |
| A synthesis of cost-utility analysis literature in infectious disease PW Stone, BR Schackman, CP Neukermans, N Olchanski, D Greenberg, ... The Lancet Infectious Diseases 5 (6), 383-391, 2005 | 22 | 2005 |
| Dementia diagnosis disparities by race and ethnicity: health services research: cost of care and implications for intervention P Lin, A Daly, N Olchanski, JT Cohen, PJ Neumann, JD Faul, HM Fillit, ... Alzheimer's & Dementia 16, e043183, 2020 | 21 | 2020 |
